Didronel en es it fr

Didronel Brand names, Didronel Analogs

Didronel Brand Names Mixture

  • No information avaliable

Didronel Chemical_Formula


Didronel RX_link


Didronel fda sheet

Didronel msds (material safety sheet)

Didronel Synthesis Reference

No information avaliable

Didronel Molecular Weight

391.46 g/mol

Didronel Melting Point

No information avaliable

Didronel H2O Solubility

10 mg/L

Didronel State


Didronel LogP


Didronel Dosage Forms

Tablets (100 mg)

Didronel Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

Didronel Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Didronel Absorption

Well absorbed from gastrointestinal tract.

Didronel side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

Didronel Patient Information

Didronel Organisms Affected

Humans and other mammals